Standout Papers

Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors 2022 2026 2023 2024282
  1. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors (2022)
    Mark Gormley, Grant Creaney et al. BDJ

Immediate Impact

17 standout
Sub-graph 1 of 7

Citing Papers

Kaempferol: Paving the path for advanced treatments in aging-related diseases
2024 Standout
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
2 intermediate papers

Works of Kate Ingarfield being referenced

Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial
2022
Epigenetic biomarkers of ageing are predictive of mortality risk in a longitudinal clinical cohort of individuals diagnosed with oropharyngeal cancer
2022

Author Peers

Author Last Decade Papers Cites
Kate Ingarfield 209 122 178 139 16 487
Anvesh Kompelli 190 65 152 123 18 439
Remco de Bree 274 118 202 98 14 532
Jonathan Harris 301 68 154 102 12 520
Samir Gupta 81 125 227 121 23 484
Marshall Levine 272 65 248 164 17 552
Ashok R. Jethwa 123 80 142 64 14 421
Elizabeth Sigston 236 84 129 156 22 428
Torbjörn Stene 140 144 171 85 13 463
Ian Witterick 263 51 157 138 11 445
Mohammad K. Hararah 76 71 263 94 20 506

All Works

Loading papers...

Rankless by CCL
2026